- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04825769
Red Light Intervention for Myopia Prevention
September 28, 2022 updated by: Shanghai Eye Disease Prevention and Treatment Center
A Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.
To explore the effectiveness of using low-intensity single-wavelength red light to prevent myopia in schoolchildren, and to provide a feasible scheme for reducing the incidence of myopia.
Study Overview
Study Type
Interventional
Enrollment (Actual)
278
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200040
- Xiangui He
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 11 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Students of grade 1-4 in the participating schools;
- Students' eyes have no myopia, that is the cycloplegic spherical equivalent(SE) >-0.50D, and at least one eye accords with the pre-myopic state, that is -0.50D <cycloplegic SE≤0.50D;
- Students whose mother and/or father are in myopia status (SE < -3.0D for either of eyes);
- Students whose parents sign informed consent and agree to let their kids participate in baseline screen and follow-up examinations and surveys.
Exclusion Criteria:
- Students whose parents do not sign informed consent;
- Students who have strabismus and/or other binocular vision abnormality;
- Students who have other eye diseases and/or systematic diseases;
- Students who have DC <=-1.5D;
- Students whose difference of SE between the two eyes >=1.5D;
- Students who meet the standards with which investigators and study physicians think it is not appropriate to enroll.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
No intervention
|
|
|
Experimental: Intervention
Red light irradiation was conducted at school from Monday to Friday and at home everyday in summer and winter holiday twice a day for 3 minutes per time, with an interval of 4 hours
|
2 times a day, 3 minutes each time, with an interval of more than 4 hours.
During the semester: From Monday to Friday, set up an intervention room in the school; For winter and summer vacation: everyday at home
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
One-year cumulative incidence of myopia (%) in the intervention group and the control group.
Time Frame: 1 year
|
Myopia is defined as the cycloplegic spherical equivalent of either eye ≤-0.5D
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The progress of spherical equivalent(SE,D) of children in intervention group and control group.
Time Frame: 1 year
|
The spherical equivalent(SE,D) will be measured by autorefractor(KR-8900, Topcon).
|
1 year
|
|
The progress of axial length of children in intervention group and control group.
Time Frame: 1 year
|
The axial length will be measured using IOLMaster.
|
1 year
|
|
The progress of choroidal thickness in children in pre-myopia state in intervention group and control group.
Time Frame: 1 year
|
The choroidal thickness will be measured using SS-OCT.
|
1 year
|
|
The change of uncorrected visual acuity (UCVA) of children in intervention group and control group.
Time Frame: 1 year
|
The uncorrected visual acuity (UCVA) will be measured using a mounted and illuminated E chart of the Early Treatment Diabetic Retinopathy study (ETDRS) charts.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Xiangui He, Shanghai Eye Disease Prevention and Treatment Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 25, 2021
Primary Completion (Actual)
August 31, 2022
Study Completion (Actual)
August 31, 2022
Study Registration Dates
First Submitted
March 24, 2021
First Submitted That Met QC Criteria
March 29, 2021
First Posted (Actual)
April 1, 2021
Study Record Updates
Last Update Posted (Actual)
September 30, 2022
Last Update Submitted That Met QC Criteria
September 28, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHYB2021001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on LLLT(Low Level Laser Therapy)
-
Federal University of Health Science of Porto AlegreUnknown
-
Federal University of Health Science of Porto AlegreUnknownCardiovascular DiseasesBrazil
-
European University of LefkeRecruitingAcute Pain | Pain Threshold | Low-level Laser Therapy | Pain Tolerance | LLLT vs ShamCyprus
-
Mashhad University of Medical SciencesUnknownMyofacial Pain SyndromeIran, Islamic Republic of
-
Universidade do Vale do SapucaiCompletedBreast Neoplasms | Radiotherapy; Adverse Effect, Dermatitis or EczemaBrazil
-
University Hospital RijekaUniversity of ZagrebCompletedPain Relief Caused by Placing Orthodontic SeparatorsCroatia
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingLow Level Laser Therapy | Third Molars Extraction | Bone HealingVietnam
-
Aga Khan UniversityCompletedPain | Periodontitis | Gingivitis | Tooth MigrationPakistan
-
Baylor UniversityRecruiting
-
Hasselt UniversityJessa HospitalCompletedHead Cancer | Neck CancerBelgium